摘要
目的通过磁共振成像(MRI)探讨非酒精性脂肪性肝病(NAFLD)患者肝脏铁沉积与脂肪变的关系。方法163例肝活检患者行肝脏MRI检查,R2*用于测定肝铁含量,基于Dixon的质子密度分数(PDFF)用于测定肝脏脂肪含量,根据肝活检病理结果通过单因素方差分析、相关性分析、受试者操作特征(ROC曲线)等分析临床病例资料、血清学指标、影像学结果之间的关系。结果随着病理脂肪变性分级越高,R2*逐步增高,无脂肪变(<5%),轻度脂肪变(14.95%±8.55%),中度脂肪变(46.30%±9.32%),重度脂肪变(73.86%±6.35%)对应的R2*分别为27.56±4.40,31.06±5.95,38.06±4.80,48.10±5.55(P<0.001),R2*和肝脏脂肪变含量呈正相关(r=0.769,P<0.05),ROC曲线下面积为0.88,截断值为31.77,与肝脏炎症和纤维化相关性不明显。结论R2*可以无创量化评估NAFLD患者肝铁沉积含量,肝脏脂肪变和铁沉积存在明显相关性,随着脂肪变加重,铁沉积也呈加重趋势。
Objective To explore the relationship between liver iron deposition and steatosis in patients with non-alcoholic fatty liver disease(NAFLD)through MRI.Methods 163 cases of liver biopsy underwent MRI examination.R2*was used to measure liver iron content.Dixon-based proton density fat fraction(PDFF)was used to measure liver fat content.One-way ANOVA,r-correlation,ROC curve,and others were used to assess the relationship between clinical case data,serological indices,and imaging results in accordance with the pathological results of the liver biopsy.Results R2*gradually increased as the pathological steatosis grade rose.The R2*that corresponded to no steatosis(<5%),mild steatosis(14.95%±8.55%),moderate steatosis(46.30%±9.32%),and severe steatosis(73.86%±6.35%)were 27.56±4.40,31.06±5.95,38.06±4.80,and 48.10±5.55(P<0.001),respectively.There was a positive correlation between R2*and liver steatosis content(r=0.769,P<0.05).The area under the ROC curve and cut-off value were 0.88 and 31.77,respectively,and there was no distinct relationship with liver inflammation or fibrosis.Conclusion R2*can quantitatively and non-invasively evaluate liver iron deposition in patients with NAFLD.A distinct relationship exists between liver steatosis and iron deposition,and iron deposition tends to increase as the steatosis aggravates.
作者
王磊
瞿欢佳
杨文君
丁建平
施军平
张秋玲
Wang Lei;Qu Huanjia;Yang Wenjun;Ding Jianping;Shi Junping;Zhang Qiuling(Department of Intensive Care Medicine,Hangzhou Normal University Affiliated Hospital,Hangzhou 310015,China;Department of Endocrinology,Hangzhou Normal University Affiliated Hospital,Hangzhou 310015,China;Department of Pathology,Hangzhou Normal University Affiliated Hospital,Hangzhou 310015,China;Department of Radiology,Hangzhou Normal University Affiliated Hospital,Hangzhou 310015,China;Department of Hepatology,Hangzhou Normal University Affiliated Hospital,Hangzhou 310015,China)
出处
《中华肝脏病杂志》
CAS
CSCD
北大核心
2023年第11期1204-1208,共5页
Chinese Journal of Hepatology
基金
浙江省医药卫生科技计划青年创新项目(2023RC234)
杭州市医药卫生科技计划重大项目(OO20191059)
浙江省医药卫生科技计划面上项目(2020KY713)。